文献速递胸部CT

IA-IIA期肺腺癌患者术后复发与影像学及临床病理特征的关联

Association of postoperative recurrence with radiological and clinicopathological features in patients with stage IA-IIA lung adenocarcinoma.
PubMed 文献 · Eur J Radiol · 2021-05-29

回顾性纳入312例活检证实的淋巴结阴性早期(IA-IIA)肺腺癌患者,术前约1个月CT用23项描述符评分。多因素分析显示IIA期、实性成分>50%或100%、胸膜附着及支气管血管束增厚为2年和5年复发的独立预测因素,影像与临床病理联合模型预测2年和5年复发的AUC分别为0.784和0.815。

要点

  • IIA期、实性成分>50%、胸膜附着是2年和5年复发的独立预测因素
  • 支气管血管束增厚仅与2年复发独立相关(OR=2.16)
  • 影像联合临床病理特征预测2年及5年复发AUC分别为0.784和0.815

核心结论

  • 影像学与临床病理特征联合有助于预测IA-IIA期肺腺癌术后复发,并可指导肿瘤科医生和患者是否在术后接受额外治疗。

研究设计与样本

  • 回顾性研究纳入312例活检证实的淋巴结阴性早期(IA-IIA)肺腺癌患者,术前约1个月行CT检查并用23项CT描述符手动评分,采用单因素分析、多因素logistic回归及ROC曲线评估预测性能。

关键影像表现/征象

  • 实性成分>50%者2年复发OR=4.81、5年复发OR=3.56,实性成分=100%者2年复发OR=3.61、5年复发OR=2.44。
  • 胸膜附着者2年复发OR=3.97、5年复发OR=4.57。
  • 支气管血管束增厚与2年复发独立相关(OR=2.16)。
  • 单因素分析显示2年复发与6项影像特征和2项临床病理特征相关,5年复发与5项影像特征和2项临床病理特征相关。

诊断标准与关键数值

  • 联合影像与临床病理特征模型预测2年复发AUC=0.784、5年复发AUC=0.815。
  • IIA期预测2年复发OR=2.87、5年复发OR=3.52。

临床应用与阅片要点

  • 阅片时可关注实性成分比例、胸膜附着及支气管血管束增厚,结合IIA期等临床病理特征评估复发风险。
  • 作者认为影像与临床病理特征联合有潜力帮助预测术后复发并指导术后是否追加治疗。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To retrospectively investigate whether radiological and clinicopathological characteristics were associated with the presence of stage IA-IIA lung adenocarcinoma in patients at high risk for a postoperative recurrence.

MATERIALS AND METHODS: Three hundred twelve patients with biopsy-proven node-negative early-stage (IA-IIA) lung adenocarcinoma met the inclusion criteria for this study. Demographics data and histopathological findings were collected from medical records. Computed tomography (CT) performed approximately 1 month before surgery was manually scored using 23 CT descriptors. Univariate analyses were applied to demonstrate an association between clinicopathological and radiological features and 2-/5-year recurrences. Multivariate logistic regression was performed to assess the ability of radiological and clinicopathological features to discriminate low and high-risk factors for recurrence. A ROC curve was used to evaluate prediction performance.

RESULTS: Univariate analysis revealed that the 2-year recurrence was associated with six radiological features and two clinicopathological features, while 5-year recurrence was associated with five radiological features and two clinicopathological features. A multivariate logistic regression model of combined clinicopathological and radiological features showed that stage IIA (OR = 2.87), solid texture (solid part > 50 %: OR = 4.81; solid part = 100 %: OR = 3.61), pleural attachment (OR = 3.97) and bronchovascular bundle thickening (OR = 2.16) were associated with the independent predictors of 2-year recurrence, and stage IIA (OR = 3.52), solid texture (solid part > 50 %: OR = 3.56; solid part = 100 %: OR = 2.44) and pleural attachment (OR = 4.57) were associated with 5-year recurrence. Combined radiological and clinicopathological features could be significant indicators of 2- and 5-year recurrences (AUC = 0.784 and AUC = 0.815, respectively).

CONCLUSIONS: The combination of radiological and clinicopathological features has the potential to help predict postoperative recurrence in patients with stage IA-IIA lung adenocarcinomas and guide oncologists and patients whether to undergo additional treatment after surgery.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Zhao F, Wu M, et al. Association of postoperative recurrence with radiological and clinicopathological features in patients with stage IA-IIA lung adenocarcinoma. Eur J Radiol. 2021. PMID: 34090112. doi:10.1016/j.ejrad.2021.109802

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。